| Identification | |
| Name: | Tazarotene |
| Synonyms: | 3-Pyridinecarboxylic acid,6-[(3,4-dihydro-4,4-dimethyl-2H-1- benzothiopyran-6-yl)ethynyl]-,ethyl ester;Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;Tazorac;Zorac;AGN 190168; |
| CAS: | 118292-40-3 |
| Molecular Formula: | C21H21NO2S |
| Molecular Weight: | 351.46194 |
| InChI: | InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3 |
| Molecular Structure: | ![(C21H21NO2S) 3-Pyridinecarboxylic acid,6-[(3,4-dihydro-4,4-dimethyl-2H-1- benzothiopyran-6-yl)ethynyl]-,ethyl est...](https://img.guidechem.com/casimg/118292-40-3.gif) |
| Properties | |
| Density: | 1.22 g/cm3 |
| Refractive index: | 1.624 |
| Water Solubility: | Well soluble in water |
| Solubility: | Well soluble in water |
| Appearance: | White Solid |
| Usage: | An acetylenic retinoid prodrug converted to the active metabolite, Tazarotenic acid, with selective affinity for retinoic acid receptors RAR?and RAR. Antiacne; antipsoriatic. Used in treatment of photodamaged skin |
| Safety Data | |
 |
|
